Geode Capital Management’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Buy |
285,332
+149,999
| +111% | +$1.12M | ﹤0.01% | 3117 |
|
|
2025
Q1 | $1.32M | Buy |
135,333
+56,090
| +71% | +$548K | ﹤0.01% | 3204 |
|
|
2024
Q4 | $429K | Sell |
79,243
-473
| -0.6% | -$2.56K | ﹤0.01% | 3652 |
|
|
2024
Q3 | $501K | Buy |
79,716
+26,489
| +50% | +$167K | ﹤0.01% | 3580 |
|
|
2024
Q2 | $337K | Sell |
53,227
-81,301
| -60% | -$515K | ﹤0.01% | 3724 |
|
|
2024
Q1 | $1.1M | Buy |
134,528
+2,871
| +2% | +$23.5K | ﹤0.01% | 3330 |
|
|
2023
Q4 | $1.1M | Buy |
131,657
+1,994
| +2% | +$16.6K | ﹤0.01% | 3324 |
|
|
2023
Q3 | $1.67M | Buy |
129,663
+17,127
| +15% | +$221K | ﹤0.01% | 3130 |
|
|
2023
Q2 | $1.8M | Buy |
112,536
+77,514
| +221% | +$1.24M | ﹤0.01% | 3147 |
|
|
2023
Q1 | $459K | Buy |
35,022
+3,654
| +12% | +$47.9K | ﹤0.01% | 3674 |
|
|
2022
Q4 | $235K | Sell |
31,368
-73
| -0.2% | -$547 | ﹤0.01% | 4008 |
|
|
2022
Q3 | $222K | Buy |
31,441
+7,474
| +31% | +$52.8K | ﹤0.01% | 4145 |
|
|
2022
Q2 | $268K | Buy |
23,967
+9,145
| +62% | +$102K | ﹤0.01% | 4090 |
|
|
2022
Q1 | $109K | Buy |
+14,822
| New | +$109K | ﹤0.01% | 4629 |
|